Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
5.61
-0.06 (-1.06%)
Oct 24, 2025, 4:00 PM EDT - Market closed
Nyxoah Revenue
Nyxoah had revenue of 1.34M EUR in the quarter ending June 30, 2025, with 73.80% growth. This brings the company's revenue in the last twelve months to 4.93M, up 2.94% year-over-year. In the year 2024, Nyxoah had annual revenue of 4.52M with 3.98% growth.
Revenue (ttm)
4.93M EUR
Revenue Growth
+2.94%
P/S Ratio
36.27
Revenue / Employee
26,868 EUR
Employees
184
Market Cap
210.10M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.52M | 173.00K | 3.98% |
| Dec 31, 2023 | 4.35M | 1.26M | 40.99% |
| Dec 31, 2022 | 3.08M | 2.23M | 261.97% |
| Dec 31, 2021 | 852.00K | 783.00K | 1,134.78% |
| Dec 31, 2020 | 69.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
NYXH News
- 21 days ago - Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System - GlobeNewsWire
- 23 days ago - Publication relating to transparency notifications - GlobeNewsWire
- 4 weeks ago - Nyxoah Provides an Update on Expanded Middle East Presence - GlobeNewsWire
- 5 weeks ago - Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc. - GlobeNewsWire
- 6 weeks ago - Nyxoah SA (NYXH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Nyxoah Announces Upcoming Investor Events - GlobeNewsWire
- 2 months ago - Nyxoah: High-Risk High-Reward Medtech To Own - Seeking Alpha
- 2 months ago - Nyxoah SA (NYXH) Q2 2025 Earnings Call Transcript - Seeking Alpha